(Q43134453)

14 November 2017

title

Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus (English)

1 reference

14 November 2017

1 reference

F Noe

1

1 reference

14 November 2017

V Vaghi

2

1 reference

14 November 2017

C Balducci

3

1 reference

14 November 2017

H Fitzsimons

4

1 reference

14 November 2017

R Bland

5

1 reference

14 November 2017

D Zardoni

6

1 reference

14 November 2017

G Sperk

7

1 reference

14 November 2017

M Carli

8

1 reference

14 November 2017

M J During

9

1 reference

14 November 2017

A Vezzani

10

1 reference

14 November 2017

publication date

11 March 2010

1 reference

14 November 2017

1 reference

14 November 2017

volume

17

1 reference

14 November 2017

issue

5

1 reference

14 November 2017

page(s)

643-652

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2010.23

14 November 2017

exact match

0 references

cites work

Long-term seizure outcome in patients initially seizure-free after resective epilepsy surgery.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Neuropeptide Y: emerging evidence for a functional role in seizure modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Neuropeptide Y as an endogenous antiepileptic, neuroprotective and pro-neurogenic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Neuroprotective effects of neuropeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Presynaptic action of neuropeptide Y in area CA1 of the rat hippocampal slice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Neuropeptide Y in the recurrent mossy fiber pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Neuropeptides in perspective: the last ten years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Central nervous system pharmacology of neuropeptide Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Neuropeptide Y (NPY) and depression: from animal studies to the human condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Diverse functions of neuropeptide Y revealed using genetically modified animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Striatal delivery of rAAV-hAADC to rats with preexisting immunity to AAV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Clinical gene therapy using recombinant adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Genetic variation in human NPY expression affects stress response and emotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Modulation of memory processing by neuropeptide Y varies with brain injection site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Stimulation of hippocampal 5-HT1A receptors causes amnesia and anxiolytic-like but not antidepressant-like effects in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

8-OH-DPAT impairs spatial but not visual learning in a water maze by stimulating 5-HT1A receptors in the hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin 1A receptor agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

Knock-out mice reveal a critical antiepileptic role for neuropeptide Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

inferred from DOI database lookup

7 January 2021

based on heuristic

Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.23

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2010.23

1 reference

Dimensions Publication ID

14 November 2017

1002594711

0 references

1 reference